|
| Tuesday, February 28, 2023 |
|
|
Leon Fuat Records Revenue of RM1.03 Billion for the FY2022 |
| LEON FUAT BERHAD, a manufacturer and trader of steel products specialising in rolled long and flat steel, today announced that the Group reported a 15.6% increase in revenue to RM1.03 billion for the financial year ended 31 December 2022 (FY2022) compared with RM886.58 million recorded for the preceding financial year (FY2021). more info >> |
|
| Monday, February 27, 2023 |
|
|
SCIB Posts Higher Revenue of RM66 Million in 1H FY2023 |
| Civil engineering specialist Sarawak Consolidated Industries Berhad (SCIB) today announced that the Group's revenue increased by 2.6% to RM66.3 million for the six months ended 31 December 2022 (1H FY2023) compared with RM64.6 million registered in the corresponding period of the previous financial year (1H FY2022). more info >> |
|
|
Malaysian Genomics to Boost Play on the Football Pitch |
| Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, is collaborating with KL City FC Sdn Bhd (KLCFC), the manager of the KL City FC football club, on the deployment of the Group's genetic screening tests for peak athletic performance. more info >> |
|
|
PT Resources Signs MoU for an International Supply Chain Intelligent Park that Integrates Digital Technology |
| PT Resources Holdings Berhad is pleased to announce that the Company has signed a memorandum of understanding (MoU) with Ocean Exchange (Fujian) Foreign Trade Services Co. Ltd to establish cooperation between the two parties for the joint development of the Malaysia East Coast International Supply Chain Intelligent Park, which is inspired by the Marche International Cold Logistics and Cross-border E-commerce Project (Fuzhou Park) located in Fujian province, China. more info >> |
|
| Friday, February 24, 2023 |
|
|
Malaysian Genomics Pivots to Biopharmaceuticals for Growth |
| Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group recorded a revenue of RM1.64 million for the second quarter ended 31 December 2022 (2Q 2023). This amount is down from RM7.63 million in 2Q 2022, as the Group moved its focus from vaccines to biopharmaceuticals. more info >> |
|
|
Malaysian Genomics to Collaborate on Cannabinoid R&D |
| Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group has entered into a strategic collaboration with Kensana Health Canada and MAHSA University for the research and development (R&D) of phytopharmaceutical and biotechnology products that can lead to commercialisation. more info >> |
|
| Thursday, February 23, 2023 |
|
|
Hektar REIT Realised Net Income higher by 187% for FY2022 |
| Hektar Asset Management Sdn. Bhd., the Manager of Hektar Real Estate Investment Trust (Hektar REIT), today announced its annual year results for the financial year ended 31 December 2022 (FY2022) with revenue of RM117.5 million, a substantial increase of 21.6% compared with the RM96.6 million for FY2021. more info >> |
|
|
Minetech Posts 58% Gain in 3Q Revenue to RM36 Million |
| Minetech Resources Berhad, a civil engineering specialist and bituminous products manufacturer, today announced that the Company registered a 58.6% gain in revenue to RM36.3 million for the third quarter ended 31 December 2022 (3Q FY2023) compared with revenue of RM22.9 million in 3Q FY2022. more info >> |
|
| Wednesday, February 22, 2023 |
|
|
Propel Global Posts 2Q Revenue of RM24.5 Million |
| Propel Global Berhad, a provider of oil and gas (O&G) services as well as downstream specialty chemicals to the O&G industry, today announced that the Group recorded a 3.81% gain in revenue to RM24.5 million for the second quarter ended 31 December 2022 (2Q FY2023) compared with RM23.6 million for the corresponding quarter in 2Q FY2022 from continuing operations. more info >> |
|
|
Malaysian Genomics to Offer World's First DNA-Driven Fertility Test |
| Malaysian Genomics Resource Centre Bhd, a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a strategic collaboration agreement with Divine Genes Sdn Bhd to collaborate on business opportunities in relation to the improvement and international distribution of genetic tests for reproductive health. more info >> |
|
|
|
